Tessa J. Kerby
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tessa J. Kerby has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Karen L. Margolis
HealthPartners, St Paul, MN, United States
3 shared publications - A. Lauren Crain
HealthPartners Institute, Minneapolis, Minnesota
2 shared publications - JoAnne M. Sperl-Hillen
HealthPartners Institute, Bloomington, USA
2 shared publications - Jody M. Jackson
Received August 28, 2013; revised and accepted November 12, 2013
2 shared publications - Michael V. Maciosek
HealthPartners Institute, Minneapolis, Minnesota
2 shared publications - Patrick J. Os’connor
Center for Chronic Care Innovation, HealthPartners Institute
2 shared publications
Latest Publications
- 1 August 2014
- Published by Wolters Kluwer Health in Menopause
- Vol. 21 (8) , 861-868
Validity of diabetes self-reports in the Women’s Health Initiative
Objective This study aims to determine the positive and negative predictive values of self-reported diabetes during the Women’s Health Initiative (WHI) clinical trials. Methods All WHI trial participants from four field centers who self-reported diabetes at baseline or during follow-up, as well as a random sample of women who did not self-report diabetes, were identified. Women were surveyed regarding diagnosis and treatment. Medical records were obtained and reviewed for documented treatment with antidiabetes medications or for physician diagnosis of diabetes supported by laboratory measurements of glucose. Results We identified 1,275 eligible participants; 732 consented and provided survey data. Medical records were obtained for 715 women (prevalent diabetes, 207; incident diabetes, 325; no diabetes, 183). Records confirmed 91.8% (95% CI, 87.0-95.0) of self-reported prevalent diabetes cases and 82.2% (95% CI, 77.5-86.1) of incident diabetes cases. Among those who never self-reported diabetes, there was no medical record or laboratory evidence for diabetes in 94.5% (95% CI, 89.9-97.2). Women with higher body mass index were more likely to accurately self-report incident diabetes. In a subgroup of participants enrolled in fee-for-service Medicare, a claims algorithm correctly classified nearly all diabetes cases and noncases. Conclusions Among WHI clinical trial participants, there are high positive predictive values of self-reported prevalent diabetes (91.8%) and incident diabetes (82.2%) and a high negative predictive value (94.5%) when diabetes is not reported. For participants enrolled in fee-for-service Medicare, a claims algorithm has high positive and negative predictive values.
- 1 August 2014
- Published by Wolters Kluwer Health in Menopause
- Vol. 21 (8) , 861-868
Validity of diabetes self-reports in the Women’s Health Initiative
Objective This study aims to determine the positive and negative predictive values of self-reported diabetes during the Women’s Health Initiative (WHI) clinical trials. Methods All WHI trial participants from four field centers who self-reported diabetes at baseline or during follow-up, as well as a random sample of women who did not self-report diabetes, were identified. Women were surveyed regarding diagnosis and treatment. Medical records were obtained and reviewed for documented treatment with antidiabetes medications or for physician diagnosis of diabetes supported by laboratory measurements of glucose. Results We identified 1,275 eligible participants; 732 consented and provided survey data. Medical records were obtained for 715 women (prevalent diabetes, 207; incident diabetes, 325; no diabetes, 183). Records confirmed 91.8% (95% CI, 87.0-95.0) of self-reported prevalent diabetes cases and 82.2% (95% CI, 77.5-86.1) of incident diabetes cases. Among those who never self-reported diabetes, there was no medical record or laboratory evidence for diabetes in 94.5% (95% CI, 89.9-97.2). Women with higher body mass index were more likely to accurately self-report incident diabetes. In a subgroup of participants enrolled in fee-for-service Medicare, a claims algorithm correctly classified nearly all diabetes cases and noncases. Conclusions Among WHI clinical trial participants, there are high positive predictive values of self-reported prevalent diabetes (91.8%) and incident diabetes (82.2%) and a high negative predictive value (94.5%) when diabetes is not reported. For participants enrolled in fee-for-service Medicare, a claims algorithm has high positive and negative predictive values.
- Top Cited Papers
Self-report compared to electronic medical record across eight adult vaccines: Do results vary by demographic factors?
- 26 July 2012
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 14 (10) , 668-674
Adherence to Blood Pressure Telemonitoring in a Cluster‐Randomized Clinical Trial
J Clin Hypertens (Greenwich). 2012;14:668–674. ©2012 Wiley Periodicals, Inc.Hypertension is a leading cause of cardiovascular disease and death worldwide. Advances in technology have added telemedicine as a tool for managing hypertension. The effectiveness of telemedicine depends on patients’ ability to adhere to schedules of home monitoring and case management. Participants with uncontrolled hypertension in the intervention arm of a randomized trial who completed 6 months of follow‐up were included in this analysis. They were asked to measure their blood pressure (BP) a minimum of 6 times per week using a telemonitor that transmitted the readings to their pharmacist case manager. Hypertensive patients in this study had high adherence to telemonitoring (73% took at least 6 BP readings per week) and phone visits (88% of expected visits were attended). In a multivariate analysis, older age, male sex, and some college education predicted better telemonitoring adherence. White non‐Hispanic race/ethnicity predicted better adherence to phone visits with pharmacist case managers. Telemonitoring adherence and phone adherence were highly correlated; participants who did not send readings on schedule were more likely to skip at least one phone visit with their pharmacist case manager. The findings from this analysis indicate that hypertensive patients in this study were able to achieve and maintain high adherence to both the telemonitoring and the phone case management visits.
- 26 July 2012
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 14 (10) , 668-674
Adherence to Blood Pressure Telemonitoring in a Cluster‐Randomized Clinical Trial
J Clin Hypertens (Greenwich). 2012;14:668–674. ©2012 Wiley Periodicals, Inc.Hypertension is a leading cause of cardiovascular disease and death worldwide. Advances in technology have added telemedicine as a tool for managing hypertension. The effectiveness of telemedicine depends on patients’ ability to adhere to schedules of home monitoring and case management. Participants with uncontrolled hypertension in the intervention arm of a randomized trial who completed 6 months of follow‐up were included in this analysis. They were asked to measure their blood pressure (BP) a minimum of 6 times per week using a telemonitor that transmitted the readings to their pharmacist case manager. Hypertensive patients in this study had high adherence to telemonitoring (73% took at least 6 BP readings per week) and phone visits (88% of expected visits were attended). In a multivariate analysis, older age, male sex, and some college education predicted better telemonitoring adherence. White non‐Hispanic race/ethnicity predicted better adherence to phone visits with pharmacist case managers. Telemonitoring adherence and phone adherence were highly correlated; participants who did not send readings on schedule were more likely to skip at least one phone visit with their pharmacist case manager. The findings from this analysis indicate that hypertensive patients in this study were able to achieve and maintain high adherence to both the telemonitoring and the phone case management visits.
- 1 July 2012
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 33 (4) , 794-803
Design and rationale for Home Blood Pressure Telemonitoring and Case Management to Control Hypertension (HyperLink): A cluster randomized trial
- 1 July 2012
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 33 (4) , 794-803
Design and rationale for Home Blood Pressure Telemonitoring and Case Management to Control Hypertension (HyperLink): A cluster randomized trial
- Open Access
- 20 October 2011
- Published by Springer Nature in BMC Research Notes
- Vol. 4 (1) , 430
Webinar Training: an acceptable, feasible and effective approach for multi-site medical record abstraction: the BOWII experience
- 20 October 2011
- Published by Springer Nature in BMC Research Notes
- Vol. 4 (1) , 430
Open AccessWebinar Training: an acceptable, feasible and effective approach for multi-site medical record abstraction: the BOWII experience